3.1.3.56	Alzheimer Disease	https://pubmed.ncbi.nlm.nih.gov/27750211/	INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis.	causal interaction	4	
3.1.3.56	Alzheimer Disease	https://pubmed.ncbi.nlm.nih.gov/27750211/	INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis.	diagnostic usage	3	
3.1.3.56	Alzheimer Disease	https://pubmed.ncbi.nlm.nih.gov/27750211/	INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis.	ongoing research	1	
3.1.3.56	Alzheimer Disease	https://pubmed.ncbi.nlm.nih.gov/27750211/	INPP5D rs35349669 polymorphism with late-onset Alzheimer's disease: A replication study and meta-analysis.	unassigned	-	
3.1.3.56	Astrocytoma	https://pubmed.ncbi.nlm.nih.gov/24358143/	Identification of novel genetic alterations in samples of malignant glioma patients.	ongoing research	2	
3.1.3.56	Astrocytoma	https://pubmed.ncbi.nlm.nih.gov/24358143/	Identification of novel genetic alterations in samples of malignant glioma patients.	unassigned	-	
3.1.3.56	Ataxia	https://pubmed.ncbi.nlm.nih.gov/26051944/	Deletion of Inpp5a causes ataxia and cerebellar degeneration in mice.	causal interaction	2	
3.1.3.56	Ataxia	https://pubmed.ncbi.nlm.nih.gov/33792664/	INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH.	causal interaction	4	
3.1.3.56	Ataxia	https://pubmed.ncbi.nlm.nih.gov/26051944/	Deletion of Inpp5a causes ataxia and cerebellar degeneration in mice.	unassigned	-	
3.1.3.56	Ataxia	https://pubmed.ncbi.nlm.nih.gov/33792664/	INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH.	unassigned	-